FEDERAL1d left

DoW Neurofibromatosis Exploration-Hypothesis Development Award

Defense Health Agency Contracting Activity - DHACA

Posted Jun 25, 2026

Deadline
Sep 22, 2026
1 days remaining
Amount
Varies
Status
Open
Geographic Scope
National

Description

Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in neurofibromatosis (NF) research. Studies supported by this award mechanism should lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design.

Distinctive Features:

• Innovation: The proposed research project should be innovative. Innovative research may introduce a novel paradigm, challenge existing paradigms, examine existing problems from novel perspectives, or exhibit other highly creative qualities.

• Preliminary Data: Preliminary and/or published data is encouraged but not required.

AI Summary

The Neurofibromatosis Research Program's Exploration-Hypothesis Development Award funds innovative research projects that explore high-risk, high-gain concepts in neurofibromatosis (NF) research, aiming to establish a foundation for future studies. Researchers with a well-formulated, testable hypothesis based on strong scientific rationale are eligible to apply.

Funding Details

Key Dates

Posted: Jun 25, 2026Deadline: Sep 22, 2026

Quick Facts

CFDA Number
12.420
Funder Type
Federal Agency
Grant Level
FEDERAL
Last Verified
Jun 26, 2026

Geographic Scope

national

ReferenceGL-1C0F27

1c0f2765-b9f9-45d9-83ef-a0a2db990e7a

Intelligence

Ready to apply?

Visit the funder's website to start your application.

DoW Neurofibromatosis Exploration-Hypothesis Development Award | GrantLens